Medicaid Reimbursement Challenges for Mohs Surgery
Britta Verhey's research on Medicaid reimbursement for Mohs micrographic surgery, a crucial treatment for skin cancer, is shedding light on the challenges of insurance coverage and healthcare access.
Verhey, a medical student at the University of Nevada, Reno School of Medicine, began exploring this topic during her undergraduate years at Stanford University. She collaborated with renowned institutions like Stanford University, the Mayo Clinic, and the University of California, San Francisco to examine Medicaid claims data from 2016 to 2022. Her findings indicate that, unexpectedly, states that expanded Medicaid under the Affordable Care Act experienced a sharper decrease in reimbursement rates for Mohs surgery. This reduction in payments could deter physicians from accepting Medicaid patients, thus hindering access to this essential procedure.
Implications for Healthcare Access and Policy
This research spotlights a significant concern: despite Mohs surgery's reputation as the gold-standard treatment for certain skin cancers, less than half of the surgeons performing it accept Medicaid. The low reimbursement rates are a primary factor, emphasizing the need for healthcare policy reviews to ensure patient access to necessary services. Such findings resonate with the broader industry discussions on balancing cost control and patient care quality.
Key Findings from Verhey’s Study
- Data covered Medicaid claims from 2016-2022.
- States with Medicaid expansion saw greater declines in reimbursement rates.
- Fewer than 50% of Mohs surgeons accept Medicaid.
The Path Forward
Verhey plans to build on her research by conducting a national study that examines how insurance types affect access to Mohs surgery, focusing on equity and access. Her long-term aim is to integrate research into her medical career while guiding future students towards impactful healthcare research. Her work, which addresses significant healthcare delivery challenges, encourages a re-evaluation of Medicaid's role in facilitating equitable healthcare access. Verhey’s commitment is a call to action for industry professionals to address the complexities of insurance policies that may inadvertently limit patient care options.